Literature DB >> 12887685

Cloning and characterization of a Caenorhabditis elegans D2-like dopamine receptor.

Satoshi Suo1, Noboru Sasagawa, Shoichi Ishiura.   

Abstract

The neurotransmitter dopamine plays an important role in the regulation of behavior in both vertebrates and invertebrates. In mammals, dopamine binds and activates two classes of dopamine receptors, D1-like and D2-like receptors. However, D2-like dopamine receptors in Caenorhabditis elegans have not yet been characterized. We have cloned a cDNA encoding a putative C. elegans D2-like dopamine receptor. The deduced amino acid sequence of the cloned cDNA shows higher sequence similarities to vertebrate D2-like dopamine receptors than to D1-like receptors. Two splice variants that differ in the length of their predicted third intracellular loops were identified. The receptor heterologously expressed in cultured cells showed high affinity binding to [125I]iodo-lysergic acid diethylamide. Dopamine showed the highest affinity for this receptor among several amine neurotransmitters tested. Activation of the heterologously expressed receptor led to the inhibition of cyclic AMP production, confirming that this receptor has the functional property of a D2-like receptor. We have also analyzed the expression pattern of this receptor and found that the receptor is expressed in several neurons including all the dopaminergic neurons in C. elegans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887685     DOI: 10.1046/j.1471-4159.2003.01896.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  42 in total

Review 1.  Monoamines activate neuropeptide signaling cascades to modulate nociception in C. elegans: a useful model for the modulation of chronic pain?

Authors:  Rick Komuniecki; Gareth Harris; Vera Hapiak; Rachel Wragg; Bruce Bamber
Journal:  Invert Neurosci       Date:  2011-12-06

2.  Drosophila Dopamine2-like receptors function as autoreceptors.

Authors:  Trisha L Vickrey; B Jill Venton
Journal:  ACS Chem Neurosci       Date:  2011-12-21       Impact factor: 4.418

Review 3.  Dopamine signaling architecture in Caenorhabditis elegans.

Authors:  Paul W McDonald; Tammy Jessen; Julie R Field; Randy D Blakely
Journal:  Cell Mol Neurobiol       Date:  2006-05-25       Impact factor: 5.046

4.  Cannabinoids Stimulate the TRP Channel-Dependent Release of Both Serotonin and Dopamine to Modulate Behavior in C. elegans.

Authors:  Mitchell Oakes; Wen Jing Law; Richard Komuniecki
Journal:  J Neurosci       Date:  2019-03-18       Impact factor: 6.167

5.  Identification of neuroprotective compounds of caenorhabditis elegans dopaminergic neurons against 6-OHDA.

Authors:  Marketa Marvanova; Charles D Nichols
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

6.  Haloperidol Interactions with the dop-3 Receptor in Caenorhabditis elegans.

Authors:  Bárbara Nunes Krum; Airton C Martins; Libânia Queirós; Beatriz Ferrer; Ginger L Milne; Félix Alexandre Antunes Soares; Roselei Fachinetto; Michael Aschner
Journal:  Mol Neurobiol       Date:  2020-09-15       Impact factor: 5.590

7.  Dopamine counteracts octopamine signalling in a neural circuit mediating food response in C. elegans.

Authors:  Satoshi Suo; Joseph G Culotti; Hubert H M Van Tol
Journal:  EMBO J       Date:  2009-07-16       Impact factor: 11.598

8.  The C. elegans D2-like dopamine receptor DOP-3 decreases behavioral sensitivity to the olfactory stimulus 1-octanol.

Authors:  Meredith J Ezak; Denise M Ferkey
Journal:  PLoS One       Date:  2010-03-02       Impact factor: 3.240

9.  Dopamine suppresses octopamine signaling in C. elegans: possible involvement of dopamine in the regulation of lifespan.

Authors:  Satoshi Suo; Joseph G Culotti; Hubert H M Van Tol
Journal:  Aging (Albany NY)       Date:  2009-10-21       Impact factor: 5.682

10.  Stimulation of movement in a quiescent, hibernation-like form of Caenorhabditis elegans by dopamine signaling.

Authors:  Marta Maria Gaglia; Cynthia Kenyon
Journal:  J Neurosci       Date:  2009-06-03       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.